EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Big Pharma Split's enterprise value is C$0.00 Mil.
Big Pharma Split's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.31 Mil. Therefore, Big Pharma Split's EV-to-Revenue for today is 0.00.
The historical rank and industry rank for Big Pharma Split's EV-to-Revenue or its related term are showing as below:
TSX:PRM.PR.A.PFD'
s EV-to-Revenue Range Over the Past 10 Years
Min: 2.29 Med: 5.39 Max: 56.02
Current: 51
During the past 7 years, the highest EV-to-Revenue of Big Pharma Split was 56.02. The lowest was 2.29. And the median was 5.39.
TSX:PRM.PR.A.PFD's EV-to-Revenue is ranked worse than 89.34% of 1445
companies
in the Asset Management industry
Industry Median: 9.47
vs TSX:PRM.PR.A.PFD: 51.00
The historical data trend for Big Pharma Split's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Big Pharma Split's EV-to-Revenue
For the Asset Management subindustry, Big Pharma Split's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Big Pharma Split's EV-to-Revenue Distribution in the Asset Management Industry
For the Asset Management industry and Financial Services sector, Big Pharma Split's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Big Pharma Split's EV-to-Revenue falls into.
Big Pharma Split's current Enterprise Value is C$0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Big Pharma Split's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.31 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Big Pharma Split (TSX:PRM.PR.A.PFD) EV-to-Revenue Explanation
Big Pharma Split's share price for today is C$9.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was C$0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Big Pharma Split EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Big Pharma Split's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Big Pharma Split (TSX:PRM.PR.A.PFD) Business Description
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSX:PRM.PR.A.PFD has been successfully added to your 